Eargo Inc is a medical devices business based in the US. Eargo shares (EAR) are listed on the NASDAQ and all prices are listed in US Dollars. Eargo employs 238 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Eargo
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – EAR – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Eargo stock price (NASDAQ: EAR)Use our graph to track the performance of EAR stocks over time.
Eargo shares at a glance
|Latest market close||$7.57|
|52-week range||$6.20 - $76.75|
|50-day moving average||$14.13|
|200-day moving average||$32.28|
|Wall St. target price||$9.93|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-1.65|
Buy Eargo shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Eargo stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Eargo price performance over time
|1 week (2021-10-15)||5.14%|
|1 month (2021-09-22)||-65.07%|
|3 months (2021-07-22)||-78.10%|
|6 months (2021-04-22)||-84.56%|
|1 year (2020-10-21)||-78.09%|
|2 years (2019-10-18)||N/A|
|3 years (2018-10-18)||N/A|
|5 years (2016-10-18)||N/A|
|Revenue TTM||$85.5 million|
|Gross profit TTM||$47.3 million|
|Return on assets TTM||-25.17%|
|Return on equity TTM||-70.11%|
|Market capitalisation||$282.7 million|
TTM: trailing 12 months
Shorting Eargo shares
There are currently 1.7 million Eargo shares held short by investors – that's known as Eargo's "short interest". This figure is 33.9% down from 2.6 million last month.
There are a few different ways that this level of interest in shorting Eargo shares can be evaluated.
Eargo's "short interest ratio" (SIR)
Eargo's "short interest ratio" (SIR) is the quantity of Eargo shares currently shorted divided by the average quantity of Eargo shares traded daily (recently around 4.3 million). Eargo's SIR currently stands at 0.4. In other words for every 100,000 Eargo shares traded daily on the market, roughly 400 shares are currently held short.
To gain some more context, you can compare Eargo's short interest ratio against those of similar companies.
However Eargo's short interest can also be evaluated against the total number of Eargo shares, or, against the total number of tradable Eargo shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Eargo's short interest could be expressed as 0.04% of the outstanding shares (for every 100,000 Eargo shares in existence, roughly 40 shares are currently held short) or 0.0726% of the tradable shares (for every 100,000 tradable Eargo shares, roughly 73 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Eargo.
Find out more about how you can short Eargo stock.
Eargo share dividends
We're not expecting Eargo to pay a dividend over the next 12 months.
Eargo, Inc. , a medical device company, develops and sells hearing aids to assist people with hearing loss in the United States. It sells its products through online stores. The company was formerly known as Aria Innovations, Inc. and changed its name to Eargo, Inc. in November 2014. Eargo, Inc.
Eargo in the news
DEADLINE ALERT for APPH, HYZN, EAR, and NNOX: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Eargo, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of December 6, 2021 - EAR
EAR ALERT - Nationally Ranked Shareholder Rights Firm Labaton Sucharow is Investigating Eargo, Inc. (NASDAQ:EAR) for Potential Securities Violations and Breach of Fiduciary Duty
Frequently asked questionsWhat percentage of Eargo is owned by insiders or institutions?
Currently 13.628% of Eargo shares are held by insiders and 101.94% by institutions. How many people work for Eargo?
Latest data suggests 238 work at Eargo. When does the fiscal year end for Eargo?
Eargo's fiscal year ends in December. Where is Eargo based?
Eargo's address is: 1600 Technology Drive, San Jose, CA, United States, 95110 What is Eargo's ISIN number?
Eargo's international securities identification number is: US2700871096
More guides on Finder
How to buy ProShares Bitcoin Strategy ETF (BITO)
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
How to buy The Real Good Food Company (RGF) stock when it goes public
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
How to buy Lulu’s Fashion Lounge Holdings (LVLU) stock when it goes public
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
How to buy Allarity Therapeutics (ALLR) stock when it goes public
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
How to buy Jupiter Neurosciences (JUNS) stock when it goes public
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
How to buy Mainz Biomed (MYNZ) stock when it goes public
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
How to buy Progressive Care stock when it goes public
Everything we know about the Progressive Care IPO, plus information on how to buy in.
How to buy Desert Peak Minerals (DPM) stock when it goes public
Everything we know about the Desert Peak Minerals IPO, plus information on how to buy in.
How to buy Vaxxinity (VAXX) stock when it goes public
Everything we know about the Vaxxinity IPO, plus information on how to buy in.
How to buy Entrada Therapeutics (TRDA) stock when it goes public
Everything we know about the Entrada Therapeutics IPO, plus information on how to buy in.
Ask an Expert